Dublin, Oct. 04, 2018 (GLOBE NEWSWIRE) — The “Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products” report has been added to ResearchAndMarkets.com’s offering.
The report focuses on select drugs (antimicrobials), environment treatment (disinfectants, sterilization systems etc.) and provisions in medical devices (e.g. catheters, patient ventilation devices, sterile IV filters) that prevent occurrence of nosocomial infections.
Within each type of treatment, regional analyses will focus on the Americas (i.e. Canada, the U.S., Mexico, Central America and South America), EMRA (i.e. Europe, the Middle East, Russia and Africa) and Asia-Pacific (i.e. Japan, China, India, other Western Pacific countries such as Australia and New Zealand and other Southeast Asian countries).
The Report Includes:
- Industry analysis of the global healthcare-acquired infection (HCAI) control market
- Detailed overview and trend analysis of pharmaceutical treatment (antimicrobials and vaccines), environment treatment (disinfectants, sterilization systems etc.) and provisions in medical devices (catheters, patient ventilation devices, sterile intravenous [IV] filters) that prevent these infections
- Analyses of global market trends with data from 2017, estimates for 2018 and projections of compound annual growth rates (CAGRs) through 2023
- Emphasis on selected devices, pharmaceuticals and environmental products currently employed or under development for treatment of viral, bacterial and fungal infections
- Analysis of antimicrobial resistance and more specifically antibiotic resistance as a cause for these infections
- A look at the hospital surveillance methods and tools currently being used to prevent these infections
- Regional analysis of the market covering Americas (i.e. Canada, the U.S., Mexico, Central America and South America), EMRA (i.e. Europe, the Middle East, Russia and Africa); and Asia-Pacific (i.e. Japan, China, India, other Western Pacific countries such as Australia and New Zealand and other Southeast Asian countries)
- Information on key patents and newer research developments in sterilization systems and devices
- Examination of vendor landscape and profiles of key players in the HCAI market, including Novartis, Pfizer, Roche, 3M Healthcare and Sanofi Pasteur
Key Topics Covered:
Chapter 1 Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources
- Methodology
- Geographic Breakdown
- Analyst’s Credentials
- Custom Research
- Related Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Overview
- Healthcare-Acquired Infections
- Types of Infections
- Central-Line-Associated Bloodstream Infections
- Surgical Site Infections
- Catheter-Associated Urinary Tract Infections
- Ventilator-Associated Pneumonia
- Diseases and Infectious Agents in Healthcare Settings
- Acinetobacter
- Burkholderia cepacia
- Clostridium difficile
- Clostridium sordellii
- Enterobacteriaceae (Carbapenem-Resistant)
- Gram-Negative Bacteria
- Hepatitis
- HIV/AIDS
- Influenza
- Klebsiella
- Methicillin-Resistant Staphylococcus aureus
- Mycobacterium abscessus
- Norovirus
- Pseudomonas aeruginosa
- Staphylococcus aureus
- Vancomycin-Resistant Enterococci
- Incidence and Prevalence
- Risk Factors
- Prevention Strategies
- Basic Infection Prevention and Control
- Antibiotics and Multidrug-Resistant Organisms
- Device-Associated Infection Control
- Procedure-Associated Guidelines
- Setting Specific Guidelines
- WHO Guidelines
- Surveillance Systems
Chapter 4 Market Summary and Analysis
- Global Infection control Market
- Region-wise Analysis
- Market Drivers
- Antimicrobial Resistance
- Increasing Population and Demographic Changes
- Emerging Markets
- New Technologies
- Vaccine Coverage
- Increase in Focus on HCAIs
- Market Deterrents
- Cost-Effectiveness of Newer Methods
- Unmet Needs
- Effective Treatment for “Superbugs”
Chapter 5 Pharmaceuticals
- HCAI Pharmaceuticals Market
- Antibiotics
- Mechanism of Action
- Antibiotics Resistance
- Mechanisms of Antibiotic Resistance
- Reasons for Antibiotic Resistance
- Antimicrobial Resistance (Antibiotics) — Incidence
- Antibiotic Resistance — Hospitals, Healthcare Settings
- Davos Declaration for Combating Antimicrobial Resistance
- Antibiotics for Bacterial HCAI
- Select Marketed Antibiotics
- Global Antibiotics Market
- Antifungal Drugs
- Antifungals for HCAI
- Select Marketed Antifungals
- Global Antifungals Market
- Antivirals and Vaccines
- Hepatitis B and Hepatitis C
- Influenza
Chapter 6 Environmental Treatment
- HCAI: Environmental Treatment Market
- Disinfectants
- Key Marketed Hospital-Use Disinfectants
- Patient Skin Preparation
- Key Marketed Patient Skin Preparation Antiseptics
- Patient Skin Preparation Market
- Environment Sterilization
- Air Treatment
- Room Filtration Systems
- Room Pressurization
- UV Light Disinfection
- Water Treatment
- Equipment/Facility Sterilization
- Heat Sterilization
- Chemical Sterilization
- Radiation-based Sterilization
- Environment Sterilization Market
Chapter 7 Medical Devices
- HCAI: Medical Devices Market
- Antimicrobial Coatings
- Catheters
- Patient Ventilation Devices
- Types of Ventilation Devices
- IV Filters
- IV Filter Market
Chapter 8 Industry Structure
- Industry Structure for Healthcare Infection Prevention
- Suppliers
- Customers
- Consumers
Chapter 9 Research and Opportunities
- New Technologies
- Hand Hygiene
- Patient Tracing
- Self-Disinfecting Surfaces
- Automated Decontamination Technologies
- Smart Systems and Predictive Analytics
- Other Technologies
- Antibiotics Pipeline
- Viral Infection Pipeline — Hepatitis B and Hepatitis C
- Pipeline of Viral Infection Influenza
- Fungal Infection Pipeline
Chapter 10 Patent Analysis
- Pharmaceuticals
- Antibiotics
- Hepatitis B
- Hepatitis C
- Influenza
- Antifungals
- Environment Sterilization
- Disinfectants
- Patient Skin Preparation
- Air Treatment
- Water Treatment
- Medical Devices
- Catheters and Endotracheal Tubes
- IV Filters (In-Line)
Chapter 11 Company Profiles
- Pharmaceutical Companies
- Gilead Sciences
- Merck
- Novartis
- Pfizer
- Roche
- Sanofi, Sanofi Pasteur
- Seqirus
- Companies In Sterilization/Disinfection Industry
- 3M Healthcare
- Advanced Sterilization Products
- Becton, Dickinson And Company
- Belimed
- Sterigenics
- The Clorox Company
- Xenex Disinfection Services
- Medical Device Companies
- Bactiguard
- Teleflex
Chapter 12 Appendix
For more information about this report visit https://www.researchandmarkets.com/research/cpck75/global?w=12
Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Medical Devices, Infectious Diseases Drugs
